David J. Hunter
About
In The Last Decade
David J. Hunter
12 papers receiving 958 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 597
- Immunology 241
- Public Health, Environmental and Occupational Health 171
- Genetics 164
- Oncology 125
Countries citing papers authored by David J. Hunter
This map shows the geographic impact of David J. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Hunter more than expected).
Fields of papers citing papers by David J. Hunter
This network shows the impact of papers produced by David J. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Hunter. The network helps show where David J. Hunter may publish in the future.
Co-authorship network of co-authors of David J. Hunter
This figure shows the co-authorship network connecting the top 25 collaborators of David J. Hunter. A scholar is included among the top collaborators of David J. Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Hunter. David J. Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 74 | |
| 2 | 32 | |
| 3 | 46 | |
| 4 | 122 | |
| 5 | A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. | 70 |
| 6 | Premenopausal dietary carbohydrate, glycemic index, glycemic load, and fiber in relation to risk of breast cancer. | 94 |
| 7 | No association between a stop codon polymorphism in RAD52 and breast cancer risk. | 8 |
| 8 | The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study. | 78 |
| 9 | 250 | |
| 10 | The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. | 67 |
| 11 | 138 | |
| 12 | Muscular dystrophy ingirls withX;autosome translocations | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.